Transcriptional and epigenetic mechanisms of addiction - PubMed (original) (raw)
Review
Transcriptional and epigenetic mechanisms of addiction
Alfred J Robison et al. Nat Rev Neurosci. 2011.
Abstract
Investigations of long-term changes in brain structure and function that accompany chronic exposure to drugs of abuse suggest that alterations in gene regulation contribute substantially to the addictive phenotype. Here, we review multiple mechanisms by which drugs alter the transcriptional potential of genes. These mechanisms range from the mobilization or repression of the transcriptional machinery - including the transcription factors ΔFOSB, cyclic AMP-responsive element binding protein (CREB) and nuclear factor-κB (NF-κB) - to epigenetics - including alterations in the accessibility of genes within their native chromatin structure induced by histone tail modifications and DNA methylation, and the regulation of gene expression by non-coding RNAs. Increasing evidence implicates these various mechanisms of gene regulation in the lasting changes that drugs of abuse induce in the brain, and offers novel inroads for addiction therapy.
Figures
Figure 1. Brain reward circuitry
The brain on the left depicts dopaminergic afferents (light blue arrows) which originate in the ventral tegmental area (blue) and release dopamine in the nucleus accumbens (red) and many other limbic targets. Also shown are other monoaminergic nuclei — the noradrenergic locus coeruleus (green) and serotonergic dorsal raphe (yellow) — which modulate drug reward and other actions. The brain on the right highlights glutamatergic regions that are important for reward: medial prefrontal cortex (green), orbitofrontal cortex (yellow), anterior cingulate cortex (dark blue), thalamus (purple), hippocampus (orange), and amygdala (aqua), all of which send excitatory projections to the nucleus accumbens (red). Drugs of abuse alter this reward circuitry in complex ways, which lead to addiction.
Figure 2. Mechanisms of transcriptional and epigenetic regulation by drugs of abuse
In eukaryotic cells, DNA is organized by wrapping around histone octomers to form nucleosomes, which are then further organized and condensed to form chromosomes (right). Only by temporarily unraveling compacted chromatin can the DNA of a specific gene be made accessible to the transcriptional machinery. Drugs (left) act through synaptic targets to alter intracellular signaling cascades, which leads to the activation or inhibition of transcription factors and of many other nuclear targets including chromatin regulatory proteins; the detailed mechanisms involved in the latter remain poorly understood. This leads to the induction or repression of particular genes, including those for noncoding RNAs; altered expression of some of these genes can in turn further regulate gene transcription. It is hypothesized that some of these drug-induced changes at the chromatin level are extremely stable and thereby underlie the long-lasting behaviors that define addiction. CREB, cAMP response element binding protein; DNMTs, DNA methyltransferases; HATs, histone acetyltransferases; HDACs, histone deacetylases; HDMs, histone demethylases; HMTs, histone methyltransferases; MEF2, myocyte enhancing factor-2; NFκB, nuclear factor κB; pol II, polymerase II.
Figure 3. Gene priming and desensitization
In addition to regulating the steady-state expression levels of certain genes, cocaine induces latent effects at many other genes, which alter their inducibility in response to a subsequent stimulus. A. Analysis of mRNA expression after acute or chronic cocaine. Heat maps marked with an asterisk (*) show all genes that are upregulated in the NAc 1 hr after a cocaine challenge in naive animals (acute), in animals treated repeatedly with cocaine (repeated + acute), or in animals after 1 wk of withdrawal from repeated cocaine (repeated wd + acute). Associated heat maps show how the same genes were affected under the other two conditions. Desensitized transcriptional responses after repeated cocaine are indicated (***). B. Early evidence suggests that epigenetic mechanisms are important in mediating such gene priming and desensitization and that many such changes are latent, meaning that they are not reflected by stable changes in steady-state mRNA levels. Rather, such changes alter chromatin structure such that later drug challenge induces a given gene to a greater (primed) or lesser (desensitized) extent based on the epigenetic modifications induced by previous chronic drug exposure. A major goal of current research is to identify the chromatin signatures that underlie gene priming and desensitization.
Figure 4. Epigenetic basis of drug regulation of gene expression
The figure is based on the mechanisms by which chronic cocaine, through ΔFosB, activates the cdk5 gene (top) and represses the c-fos gene (bottom). Top: ΔFosB binds to the cdk5 gene and recruits several co-activators, including CBP (CREB binding protein) — a type of histone acetyltransferase (HAT) leading to increased histone acetylation, transcription factor BRG1 (also known as brahma-related gene 1) — a type of chromatin remodeling factor — and SUG1 (proteasome 26S ATPase subunit 5), another type of chromatin regulatory protein. ΔFosB also represses G9a expression, leading to reduced repressive histone methylation at the cdk5 gene. The net result is gene activation and increased CDK5 expression. Bottom: In contrast, ΔFosB binds to the c-fos gene and recruits several co-repressors, including HDAC1 (histone deacetylase 1) and SIRT 1 (sirtuin 1). The gene also shows increased G9a binding and repressive histone methylation (despite global decreases in these marks). The net result is c-fos gene repression. As transcriptional regulatory complexes contain dozens or hundreds of proteins, much further work is needed to further define the activational and repressive complexes that cocaine recruits to particular genes to mediate their transcriptional regulation and to explore the range of distinct activational and repressive complexes involved in cocaine action.
Similar articles
- Epigenetic mechanisms in drug addiction.
Renthal W, Nestler EJ. Renthal W, et al. Trends Mol Med. 2008 Aug;14(8):341-50. doi: 10.1016/j.molmed.2008.06.004. Epub 2008 Jul 16. Trends Mol Med. 2008. PMID: 18635399 Free PMC article. Review. - Drugs and addiction: an introduction to epigenetics.
Wong CC, Mill J, Fernandes C. Wong CC, et al. Addiction. 2011 Mar;106(3):480-9. doi: 10.1111/j.1360-0443.2010.03321.x. Addiction. 2011. PMID: 21205049 Review. - The epigenetic landscape of addiction.
Maze I, Nestler EJ. Maze I, et al. Ann N Y Acad Sci. 2011 Jan;1216:99-113. doi: 10.1111/j.1749-6632.2010.05893.x. Ann N Y Acad Sci. 2011. PMID: 21272014 Free PMC article. Review. - Neuroepigenetics and addictive behaviors: Where do we stand?
De Sa Nogueira D, Merienne K, Befort K. De Sa Nogueira D, et al. Neurosci Biobehav Rev. 2019 Nov;106:58-72. doi: 10.1016/j.neubiorev.2018.08.018. Epub 2018 Sep 8. Neurosci Biobehav Rev. 2019. PMID: 30205119 Review. - Epigenetics of drug abuse: predisposition or response.
Nielsen DA, Utrankar A, Reyes JA, Simons DD, Kosten TR. Nielsen DA, et al. Pharmacogenomics. 2012 Jul;13(10):1149-60. doi: 10.2217/pgs.12.94. Pharmacogenomics. 2012. PMID: 22909205 Free PMC article. Review.
Cited by
- Elucidating the molecular symphony: unweaving the transcriptional & epigenetic pathways underlying neuroplasticity in opioid dependence and withdrawal.
Wani SN, Grewal AK, Khan H, Singh TG. Wani SN, et al. Psychopharmacology (Berl). 2024 Sep 10. doi: 10.1007/s00213-024-06684-9. Online ahead of print. Psychopharmacology (Berl). 2024. PMID: 39254835 Review. - Intergenerational epigenetic inheritance mediated by MYS-2/MOF in the pathogenesis of Alzheimer's disease.
Li Y, Bai H, Liu W, Zhou W, Gu H, Zhao P, Zhu M, Li Y, Yan X, Zhao N, Huang X. Li Y, et al. iScience. 2024 Jul 25;27(8):110588. doi: 10.1016/j.isci.2024.110588. eCollection 2024 Aug 16. iScience. 2024. PMID: 39220410 Free PMC article. - Human genetics and epigenetics of alcohol use disorder.
Zhou H, Gelernter J. Zhou H, et al. J Clin Invest. 2024 Aug 15;134(16):e172885. doi: 10.1172/JCI172885. J Clin Invest. 2024. PMID: 39145449 Free PMC article. Review. - How much online pornography is too much? A comparison of two theoretically distinct assessment scales.
Vera Cruz G, Aboujaoude E, Liberacka-Dwojak M, Wiłkość-Dębczyńska M, Rochat L, Khan R, Khazaal Y. Vera Cruz G, et al. Arch Public Health. 2024 May 30;82(1):79. doi: 10.1186/s13690-024-01294-5. Arch Public Health. 2024. PMID: 38816773 Free PMC article. - Dopamine Pharmacodynamics: New Insights.
Lauretani F, Giallauria F, Testa C, Zinni C, Lorenzi B, Zucchini I, Salvi M, Napoli R, Maggio MG. Lauretani F, et al. Int J Mol Sci. 2024 May 13;25(10):5293. doi: 10.3390/ijms25105293. Int J Mol Sci. 2024. PMID: 38791331 Free PMC article. Review.
References
- Henikoff S, Matzke MA. Exploring and explaining epigenetic effects. Trends Genet. 1997;13:293–295. S0168952597012195 [pii] - PubMed
- Sutherland JE, Costa M. Epigenetics and the environment. Ann N Y Acad Sci. 2003;983:151–160. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 DA014133-13/DA/NIDA NIH HHS/United States
- P01 DA008227-21/DA/NIDA NIH HHS/United States
- R01 MH051399/MH/NIMH NIH HHS/United States
- R01 MH051399-21/MH/NIMH NIH HHS/United States
- R01 DA014133/DA/NIDA NIH HHS/United States
- P01 DA008227/DA/NIDA NIH HHS/United States
- P01 DA008227-20/DA/NIDA NIH HHS/United States
- R01 DA014133-12/DA/NIDA NIH HHS/United States
- R01 MH051399-20/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical